L&C Bio, Medipost Lead Biotech Rally-How Far Can They Go?[K-Bio Pulse] 유진희 2025.09.15 오전 09:00 Biopharma Earnings Drive Undervalued Stocks Higher, L&C Bio Extends Rally[K-Bio Pulse] 유진희 2025.09.09 오전 09:30 Cellbion Reports Positive Phase 2 Results in Prostate Cancer Therapy 유진희 2025.09.04 오후 06:00 Cellbion’s radiotherapy shows 35% ORR, looks to expand Merck ties 유진희 2025.09.05 오전 08:30 From Corestem to Yuhan: Cellbion Eyes Fast-Track Path for Lu-177-DGUL 유진희 2025.08.27 오전 08:27 DXVX Soars on First License-Out DealNature Cell[K-Bio Pulse] 유진희 2025.07.31 오전 09:00 Wonik Soars on Policy Tailwinds; Y2Solution Gains on Licensing Buzz[K-Bio Pulse] 유진희 2025.06.05 오전 09:10 Cellbion Starts Merck Trial, Targets Global Sales and Licensing 유진희 2025.06.05 오전 10:53 AdBiotech and HK Inno.N Surge on Future Value Hopes[K-Bio Pulse] 유진희 2025.06.10 오전 08:12 AdBiotech Rallies on Biotech Breakthrough Hopes[K-Bio Pulse] 유진희 2025.06.11 오전 08:11 더 보기 로딩중..